# A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

> **NCT01072929** · PHASE3 · COMPLETED · sponsor: **Cephalon** · enrollment: 433 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Armodafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01072929
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 433 (ACTUAL)
- **Last updated:** 2016-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072929, "A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01072929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*